Doki, Yuichiro
The University of Osaka
12 papers on CoChatORCID 0000-0001-7346-0209
Most cited papers
- Verified
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Saito, T., Nishikawa, H., Wada, H., Nagano, Y., Sugiyama, D., Atarashi, K., Maeda, Y., Hamaguchi, M., Ohkura, N., Sato, E., et al. (2016) · Nature Medicine
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 871
- Verified
CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory
Kidani, Y., Nogami, W., Yasumizu, Y., Kawashima, A., Tanaka, A., Sonoda, Y., Tona, Y., Nashiki, K., Matsumoto, R., Hagiwara, M., et al. (2022) · Proceedings of the National Academy of Sciences
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 212
- Verified
Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer
Takahashi, Y., Sawada, G., Kurashige, J., Uchi, R., Matsumura, T., Ueo, H., Takano, Y., Akiyoshi, S., Eguchi, H., Sudo, T., et al. (2013) · British Journal of Cancer
Cancer Cells and MetastasisMechanisms of cancer metastasis
Cited by 92
- Verified
Tumor‐infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer
Yamamoto, K., Makino, T., Sato, E., Noma, T., Urakawa, S., Takeoka, T., Yamashita, K., Saito, T., Tanaka, K., Takahashi, T., et al. (2020) · Cancer Science
Immune cells in cancerEsophageal Cancer Research and Treatment
Cited by 85
- Verified
The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives
Takeda, M., Yoshida, S., Inoue, T., Sekido, Y., Hata, T., Hamabe, A., Ogino, T., Miyoshi, N., Uemura, M., Yamamoto, H., et al. (2025) · Cancers
Colorectal Cancer Treatments and StudiesProtein Kinase Regulation and GTPase Signaling
Cited by 82
- Verified
The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinomas of the thoracic esophagus
Matsuyama, J., Doki, Y., Yasuda, T., Miyata, H., Fujiwara, Y., Takiguchi, S., Yamasaki, M., Makari, Y., Matsuura, N., Mano, M., et al. (2007) · Surgery
Esophageal Cancer Research and TreatmentGastric Cancer Management and Outcomes
Cited by 64
- Verified
The mitochondrial one-carbon metabolic pathway is associated with patient survival in pancreatic cancer
Noguchi, K., Konno, M., Koseki, J., Nishida, N., Kawamoto, K., Yamada, D., Asaoka, T., Noda, T., Wada, H., Gotoh, K., et al. (2018) · Oncology Letters
Pancreatic and Hepatic Oncology ResearchFolate and B Vitamins Research
Cited by 60
- Verified
Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer
Kitakaze, M., Uemura, M., Hara, T., Chijimatsu, R., Motooka, D., Hirai, T., Konno, M., Okuzaki, D., Sekido, Y., Hata, T., et al. (2023) · British Journal of Cancer
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 49
- Verified
Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer
Kishi, K., Doki, Y., Miyata, H., Yano, M., Yasuda, T., & Monden, M. (2002) · British Journal of Surgery
Esophageal Cancer Research and TreatmentHead and Neck Cancer Studies
Cited by 47
- Verified
Prediction of recurrence in advanced gastric cancer patients after curative resection by gene expression profiling
Motoori, M., Takemasa, I., Yano, M., Saito, S., Miyata, H., Takiguchi, S., Fujiwara, Y., Yasuda, T., Doki, Y., Kurokawa, Y., et al. (2005) · International Journal of Cancer
Gastric Cancer Management and OutcomesGene expression and cancer classification
Cited by 39
- Verified
Clinical significance of the second cycle response to cisplatin-based chemotherapy as preoperative treatment for esophageal squamous cell carcinoma
Akita, H., Doki, Y., Miyata, H., Hirao, T., Yano, M., Takachi, K., Miyashiro, I., Sasaki, Y., Ishikawa, O., Ohigashi, H., et al. (2006) · Journal of Surgical Oncology
Esophageal Cancer Research and TreatmentGastric Cancer Management and Outcomes
Cited by 28
- Verified
A Phase II Study of Combined Chemotherapy with 5-Week Cycles of S-1 and CPT-11 plus Bevacizumab in Patients with Metastatic Colon Cancer
Mizushima, T., Ide, Y., Murata, K., Ohashi, I., Yasumasa, K., Fukunaga, M., Takemoto, H., Tamagawa, H., Hasegawa, J., Hata, T., et al. (2013) · Oncology
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free